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Introduction: That schizophrenia has a better course and
outcome in developing countries has become an axiom in
international psychiatry. This is based primarily on a series
of cross-national studies by the World Health Organiza-
tion (WHO). However, increasing evidence from other
research indicates a far more complex picture. Methods:
Literature review and tabulation of data from 23 longitu-
dinal studies of schizophrenia outcomes in 11 low- and
middle-income countries. Results: We reviewed the evi-
dence about the following domains: clinical outcomes
andpatternsofcourse,disabilityandsocialoutcomes(mar-
ital and occupational status, in particular), and untreated
samples and duration of untreated psychosis. Outcomes
varied across the studies and the evidence suggests
a need to reexamine the conclusions of the WHO studies.
Additionally, assessments of outcomes should take excess
mortality and suicide into account. Conclusions: It is time
to reexamine presumed wisdom about schizophrenia out-
comes in low- and middle-income countries.
Key words: longitudinal studies/cross-cultural
psychiatry/schizophrenia
Introduction
That schizophrenia has a better course and outcome in
countries of the developing world has become an axiom
in international psychiatry.
1–5 This belief emerges from
a long history of cross-national research,
6–9 with the
most often cited evidence coming from 3 studies by
World Health Organization (WHO): the International
Pilot Study of Schizophrenia,
10 the Determinants of Out-
come of Severe Mental Disorder (DOSMeD),
11 and the
International Study of Schizophrenia (ISoS).
12 These
studies have been cited as ‘‘arguably the greatest achieve-
ments in psychiatric epidemiology,’’
13 and their results as
constituting‘‘thesinglemost important’’ findingin cross-
cultural psychiatry.
14 No doubt the recent publication of
thefinalISoSreport
15willbolsterconvictionsinthe‘‘bet-
ter prognosis’’ hypothesis and may lead to the conclusion
that further examination of the question is not necessary.
This would be unfortunate given increasing evidence,
which presents a far more complex picture. In this review
of research conducted independently of the WHO stud-
ies, we examine clinical outcomes and patterns of course,
disability and social outcomes, and mortality and suicide
in people with schizophrenia living in low- and middle-
income countries. We also consider evidence about the
role of families, gender effects, and the implications of
evidence concerning persons with schizophrenia who
have not received biomedical treatment.
Methods
To locate research on schizophrenia outcomes in devel-
oping countries, we conducted searches of PubMed
and PsycInfo using the following keywords: schizophre-
nia, psychosis, outcome, and developing countries. This
strategy identified only a limited number of studies, and
we came to rely on a combination of keyword and author
searches, as well as tracking down references cited in
research reports, a strategy similar to the one used by
Bromet et al.
16 Inclusion criteria were research site in
a low- or middle-income country (as defined by the
World Bank
17), minimum of 1-year follow-up (either
prospective or retrospective), and English language.
We did not use the developing/developed country vari-
able because it is difficult to operationalize.
18,19
Following this strategy, we found published reports
from 23 research projects on schizophrenia outcomes
in 11 low- and middle-income countries (Brazil, Bulgaria,
China, Colombia, Ethiopia, India, Indonesia, Jamaica,
Nigeria, South Africa, and Trinidad—see tables 1 and 2),
a greater diversity of sociocultural environments than
represented in ISoS. The identified studies were
prospective and retrospective, had follow-up periods
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229ranging from 1 to 20 years, included prevalent and first-
episode cases, and drew samples from a variety of settings
(outpatient clinics, hospital samples, and communities).
Twelve of the studies followed 100 or more subjects.
Rates of attrition (not due to mortality) were generally
low to moderate in most of the prospective studies.
The heterogeneity in types of samples, follow-up
periods, and outcome measures made it impossible to
conductmeta-analyses.Ourresultsarebasedonareading
of the research reports, tabulations of the available data,
and interpretations of the evidence. To provide a basis for
comparison, we have included data from the following
ISoS sites—Bulgaria, China, India (Agra, urban Chandi-
garh, and rural Chandigarh), and Colombia. To represent
WHO research in Nigeria, we include data on 2-year
outcomes in the DOSMeD site in Ibadan.
11 Even though
the Madras Longitudinal Study (MLS)
20,21 was included
in ISoS, we have listed it as a separate study because it
was conducted independently of the WHO research.
Data for MLS are taken from reports in journals and
not from the ISoS publication. Madras is the former
name for Chennai. Hong Kong was excluded because it
is classified by theWorldBankas ahigh-income country.
17
Three studies, the Indian Multisite Study,
22 the MLS,
and the one in Bali, Indonesia,
23,24 have published results
from different follow-up periods. To provide as much de-
tail as possible about these cohorts, data from each fol-
low-up period are presented separately in the tables. It
should also be noted that the MLS cohort was originally
part of the Multisite Study, and that the research in Indo-
nesia began as a 5-year retrospective study and then pro-
spectively followed the cohort for another 6 years.
Therefore, data about the same subjects are sometimes
presented in more than one place in each of the tables.
Table 1. Prospective Studies of Schizophrenia Outcomes in Low-Income Countries
Site
Follow-up
(y) Sample Type
Baseline
(N)
Lost to
Follow-up (%)
Mortality
(%)
Follow-up
(%)
Sa ˜o Paulo, Brazil
37,38,52,64 2 Hospital 124 11.3 5.6 83.1
Sichuan, China
29,51,61,81 10
a Community 510 7.8 19.2 72.9
Butajira, Ethiopia
32,33,42 1–4 Community 321 15.6 10.3 84.4
b
Chandigarh, India
27 4.5–6þ Clinic 174 35.1 7.5 57.5
Chandigarh, India
28,82 1.5–2.5 Clinic 112 16.1 2.7 81.2
Multisite study, India
22,25,83 2 Clinic 386 11.9 4.4 83.7
Multisite study, India
22,26,84 5 Clinic 386 NA NA
c 74.4
MLS,
d India
21,30,31,44,45,85,86 10 Clinic 90 5.6 10.0 84.4
First episode
MLS, India
20 20 Clinic 90 14.4 17.8 67.8
First episode
Chennai,
e India
36,43,46 1 Community 49 0.0 0.0 100.0
Rural Karnataka, India
41 1.5 Community 100 1.0 6.0 93.0
Bali, Indonesia
23,54 11
f Hospital 59 1.7 20.3 78.0
Jamaica
39,87 1 Community 317 2.8 0.9 96.2
First episode
Ilesa, Nigeria
53 2.1–3.2 Hospital 116 11.2 7.8 81.0
Cape Town, South Africa
47 2 Hospital 57 15.8 NA 84.2
First episode
Trinidad
88 1 Community 46 6.5 NA 93.5
First episode
WHO studies
Sofia, Bulgaria
15 16 First episode 60 5.0 3.0 91.7
g
China
15 12 First episode 89 12.4 22.5 65.2
Cali, Colombia
15 26 Clinic 101 16.8 11.9 71.3
Agra, India
15 26 Clinic 140 25.7 30.7 43.6
Chandigarh (rural), India
15 15 First episode 54 13.0 18.5 68.5
Chandigarh (urban), India
15 15 First episode 155 39.4 9.0 51.6
Ibadan, Nigeria
11 2 First episode 142 31.0 NA 69.0
Note: MLS, Madras Longitudinal Study; NA, not applicable.
aOutcomes based on 2-y follow-up of untreated subjects, mortality based on 10-y follow-up.
bEighteen cases who had died were included in follow-up analyses.
cBy year 5, 12 subjects (3.1%) had committed suicide.
dResults from this study included in International Study of Schizophrenia.
eSurvey identified 265 persons with schizophrenia. Of these, 75 had never received treatment. Of this subsample, 49 accepted treatment
and were followed-up.
fFive-year retrospective study served as baseline.
gForty percent of subjects included were not interviewed. Follow-up assessments were based on medical records.
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Clinical Outcomes and Patterns of Course
Tables 3 and 4 summarize the evidence on clinical out-
comes and patterns of course. Most notable is the
wide variation across studies. First, the proportion of
individuals who experience chronic pattern of course
ranges from 4.5% (over 5 years) in the Multisite Study
in India
22,25,26 to 51.7% (over 12 years) in the ISoS China
sites.
15 Second, there is variation in the proportion of
individuals who are assessed as suffering from severe
or chronic psychotic symptoms at follow-up: from
a low of 0.0% or 5.0% in the ISoS Chandigarh rural
and urban sites, respectively, to 29.2% in the ISoS China
sites,
15 to more than 30% in 2 earlier studies in Chandi-
garh.
27,28 At 2-year follow-up, 77.9% of the cohort in ru-
ralChinawere assessed asexperiencingeither ‘‘continued
marked symptoms’’ or ‘‘further deterioration of illness.
29
Third, impressions of patterns of course may change over
time. This is apparent in 2 Indian studies. At 2-year fol-
low-up, the overall patterns of course for subjects in the
Multisite Study
22 were Best (45.2% complete recovery or
no relapses), Intermediate (44.3%  1 relapses with com-
pleteorincompleteremission),andWorst(10.5%chronic
psychosis). By 5-year follow-up, the proportion of sub-
jects categorized as having Best pattern of course had
fallen to 28.2%, and the proportion in the Worst category
had fallen to 4.5%. In contrast, the proportion of subjects
categorized as having an Intermediate pattern of course
had increased to 67.2%. In other words, over time, some
subjects in the Best category experienced relapses and
some subjects in the Worst category experienced im-
provement.AttheendoftheMultisiteStudy,theMadras
cohort continued to be followed in the MLS.
20,21,30 At
10-year follow-up, the cohort displayed a continued shift
of more subjects into the Intermediate category: Best,
17.1%; Intermediate, 76.3; Worst, 6.6%. At 20-year
follow-up, 16.4% of subjects were evenly divided into
the Best and Worst categories, while the proportion in
the Intermediate category had increased to 83.6%.
Thus, although relatively few individuals experienced
chronic symptoms, over time the majority experienced
relapse.
Disability and Social Outcomes
Tables 5 and 6 summarize the evidence on disability and
social functioning. Once again, there is wide variation. In
India and Indonesia disability and social outcomes tend
to be good, while those in China, Brazil, and Ethiopia
tend to be poor.
Variation Is Also Found in Two Speciﬁc Domains:
Marriage and Employment
In high income countries, persons with schizophrenia
have been found to have low rates of marriage. As a con-
sequence, there is often an implicit assumption that high
rates of marriage among persons with schizophrenia is an
indicator of sociocultural environments that promote
better course and outcome.
31 Table 7 summarizes the
data we found about marital status. If one looks at the
category ‘‘ever married,’’ most rates are relatively high:
Ethiopia (70.0%),
32–34 Nigeria (60.8%
35), Indonesia
(63.0% at 11-year follow-up
23), and Chennai, India
(60.9%
36and 69.7%
30). However, rates of marriage at
times of assessment were well below those for the respec-
tive general populations (table 7). Furthermore, separa-
tion and divorce were fairly common for subjects in
a number of cohorts—Brazil (15.4%),
37,38 Ethiopia
(’17.9),
32,33 and Chennai (39.6%)
36—and much higher
than those of general populations. A retrospective study
in Nigeria
35 found that 27.5% of the sample had experi-
enced marital breakup while 39.2% had never been mar-
ried. Regarding men, a large majority (66.1%) had never
married. Gureje and Bamidele
35 note, ‘‘The finding that
less than 40% of the male sample with a mean current age
of about 36 years had ever married is indicative of severe
social disability.’’ At the same time, 42.6% of ‘‘ever mar-
ried’’ women had experienced divorce or separation, a
rate about 16 times greater than that of the general
population.
Employmentstatusisalsoconsideredanimportantmea-
sure of disability in schizophrenia,
39 and the extent to
whichsocietiesofferopportunitiesforgainfulemployment,
and thus, social reintegration is thought to be associated
with course and outcome.
40 Table 8 summarizes data on
employment and household work. Even within India, the
Table 2. Retrospective Studies of Schizophrenia Outcomes in Low-Income Countries
Site
Follow-up
(y) Sample
Baseline
(N)
Lost to
Follow-up (%)
Mortality
(%)
Follow-up
(%)
Bali, Indonesia
24,89 5 Hospital 59 1.7 11.9 86.4
Lagos, Nigeria
90 2 Hospital 23 NA NA NA
Ibadan, Nigeria
63 7–26 Hospital 142 NA NA NA
Abeokuta, Nigeria
35 13 Clinic 140 14.3 NA 85.7
Note: NA, not applicable.
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Questioning an AxiomTable 3. Clinical Outcomes or Patterns of Course, Prospective Studies
Site
Psychiatric
Assessment
Follow-up
(y)
d Clinical Outcomes
s Patterns of Course (%)
Jamaica
39 PSE 1 s 13: 1-y relapse rate
Trinidad
88 PSE 1 d 19.6: Poor outcome
a
Chennai,
b India
43,46 PSE 1 d 28.6: Complete recovery without relapse or exacerbation
PHSS
Rural Karnataka, India
41 PANSS 1.5 d Much improved
c
Sa ˜o Paulo, Brazil
64 PSE 2 d 23.8: Symptom free
d 60.2:  1 psychotic symptom
Sichuan,
d China
29 PSE 2 d 22.1: Complete/partial remission
d 71.6: Continued marked symptoms
d 6.3: Further deterioration of illness
GPIS s 8.3: Relapse rate per year
Multisite study, India
22,25,26 PSE 2 s 45.2: Complete recovery or no relapses, residual symptoms
s 44.3:  1 relapses with complete or incomplete remissions
s 10.5: Chronic psychosis
PPHS
Chandigarh, India
28 PSE 1.5–2.5 d 37.4: No/minimal psychotic symptoms
d 28.6: Mild/moderate psychotic symptoms
d 34.1: Chronic psychosis
Ilesa, Nigeria
53 PSE 2.1–3.2 d 45.7: No current mental disorder
d 36.2: Active/residual schizophrenia
d 18.1: Other/Dead
BPRS
Butajira, Ethiopia
33 SANS 1–4 d 45-50: No positive symptoms during follow-up
e
d 24-54: No negative symptoms during follow-up
f SAPS
Chandigarh, India
27 NA 4.5–6þ s 45: No psychotic symptoms, some nonpsychotic symptoms
s 23: Relapses with remission
s 32: Chronic psychosis
Multisite study, India
22,25,26 PSE 5 s 28.2: Complete recovery or no relapses, residual symptoms
s 67.2:  1 relapses with complete or incomplete remissions
s 4.5: Chronic psychosis
PPHS
MLS, India
20,21,30 PSE 10 s 17.1: Complete recovery or no relapses, residual symptoms
s 76.3:  1 relapses with complete or incomplete remissions
s 6.6: Chronic psychosis
PPHS
Bali, Indonesia
23 DSM-IV-TR 11
g d 23.9: In remission
h
d 19.6: In partial remission
MLS, India
20 PSE 20 s 8.2: Complete recovery or no relapses, residual symptoms
s 83.6:  1 relapses with complete or incomplete remissions
s 8.2: Chronic psychosis
PPHS
WHO studies
Sofia, Bulgaria
15 GAF-S 16 Last 2 y
s 38.2: No psychotic symptoms
s 12.7: Episodic
s 45.5: Continuous psychotic symptoms
s 3.6: Not classified
BSPSS 16-y course
i
s 41.8: Continuous psychotic symptoms
s 54.5: Episodic
s 3.6: Not classified
China (ISoS)
15 GAF-S 12 Previous month
d 48.2: None or mild symptoms
d 29.2: Severe symptoms
BSPSS Last 2 y
s 34.5: No psychotic episodes
s 6.9: Episodic
s 51.7: Continuously psychotic
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Site
Psychiatric
Assessment
Follow-up
(y)
d Clinical Outcomes
s Patterns of Course (%)
Cali, Colombia (ISoS)
15 GAF-S 26 Previous month
d 31: None or minimal symptoms
d 20: Mild symptoms
d 20: Moderate symptoms
d 30: Serious symptoms
26-y course
s 48.6: Episodic
j
s 18.1:  1 relapses with complete or incomplete remissions
s 33.3: Continuous psychosis
Agra, India (ISoS)
15 GAF-S 25 Previous month
d 56.4 (men): none or mild symptoms
d 77.3 (women): none or mild symptoms
BSPSS Last 2 y
d 77.0: Recovered
d 11.5: Severe symptoms
s 32.1: Asymptomatic for 21–25 y
s 14.8: Asymptomatic for 6–20 y
s 13.1: Asymptomatic for <5y
s 41.0: Symptomatic for entire period
Chandigarh (rural), India (ISoS)
15 GAF-S 15 Previous month
d 61: Recovered
d 16: Moderate symptoms
d 24: Mild symptoms
BSPSS Course previous 2 y
k
s 71: No psychotic episodes
s 8: Episodic
s 8: Continuously psychotic
Chandigarh (urban), India (ISoS)
15 GAF-S 15 Previous month
d 66: Recovered
d 18: Mild symptoms
d 11: Moderate symptoms
d 5: Severe symptoms
BSPSS Course previous 2 y
l
s 64: No psychotic episodes
s 9: Episodic
s 19: Continuously psychotic
Ibadan, Nigeria
11 2 2-y course
d 81.7: Complete remission
d 15.3: Incomplete remission
d 2.0: Unremitting psychosis
d 1.0: Unknown
Note: DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision; PSE, Present State
Examination; PHSS, Psychiatric History and Sociodemographic Schedule; PANSS, Positive and Negative Symptom Scale; GPIS,
General Psychiatric Interview Schedule; PPHS, Psychiatric and Personal History Schedule; BPRS, Brief Psychiatric Rating Scale;
SANS, Scale for Assessment of Negative Symptoms; SAPS, Scale for Assessment of Positive Symptoms; MLS, Madras Longitudinal
Study; ISoS, International Study of Schizophrenia; GAF-S, Global Assessment of Functioning-Symptomatology; BSPSS, Bleuler
Severity of Psychotic Symptoms Scale.
aContinuation of initial psychotic episode, suicide, or recurrence of psychotic symptoms after being symptom free for at least 3 mo.
bUntreated at baseline.
cPANSS total score of 38.85.
dOutcomes based on 95 subjects who did not receive treatment during follow-up.
eSignificant reduction between baseline and follow-up (P < .001).
fSignificant reduction between baseline and follow-up (P < .001).
gFive-year retrospective study served as baseline.
hPANSS total score of 74.50 (moderately ill); all PANSS scores unchanged from baseline at 5 y.
iNo subjects were free of psychotic symptoms throughout the entire period.
jOnly 4.2% had a single episode.
kNo information on the other 13% of sample.
lNo information on the other 8% of sample.
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Questioning an Axiomvariation is striking: in rural Karnataka, only 13% of the
sample had regular employment,
41 whereas in the Multi-
site Study more than 80% of the sample was employed in
some capacity.
22,25,26 In Brazil, more than 50% of the
sample had either no occupation or were not working be-
cause they were receiving a sickness benefit.
38 Rates of
unemployment were similar in Indonesia (41.3%)
23 and
Ethiopia (45.3%).
42
Most research in India has found that a high propor-
tion of personswith schizophreniaare either employed or
engaged in household work, and several studies have
assessed how well subjects were performing these tasks.
TheworkbySrinivasanandThara
43,44is especiallyinfor-
mative. First, occupational status was assessed annually
for 10 years. Second, outcomes for men and women were
considered separately because of their distinct occupa-
tional domains—employment and household work, re-
spectively. Third, criteria were established (time in
occupation and level of performance) for categorizing
outcomes. At year 10, 52.5% and 47.5% of men were clas-
sified as having good or poor employment outcomes, re-
spectively. This presents a different impression than the
data on whether men had been employed during the pre-
vious year, which ranged between 63% and 73% during
the follow-up period.
43 Two-thirds of women were rated
as having good home-making functioning. However, it is
difficult to determine the extent to which functional abil-
ities were required to perform assigned household tasks
(cooking, washing clothes and utensils, household main-
tenance, caring for children, and others in the household)
because other women in the household generally helped
with these tasks.
Lack of Biomedical Treatment
Several studies conducted research among persons who
had not received biomedical treatment. This is of partic-
ular interest because the ‘‘better prognosis’’ hypothesis
implies that the ‘‘natural’’ course of schizophrenia will
be relatively benign in the developing world.
29
A community survey in rural China identified 510
persons who had a current diagnosis or history of schizo-
phrenia.
29 Of these, 30.6% had never received treatments
of any kind, while 5.9% were receiving regular antipsy-
chotic medication, 42.7% had histories of hospitalization
and/or irregular treatment, and 20.8% had received tra-
ditional Chinese treatments. At baseline, lack of treat-
ment of any kind and duration of untreated psychosis
(DUP)greaterthanayearwereassociatedwithpoorclin-
ical status. At 2-year follow-up, the 95 subjects who had
gone without treatment were, on average, assessed as
having poor clinical status.
In rural Ethiopia, a community survey identified 321
persons with schizophrenia of whom 88.8% had never re-
ceived treatment with antipsychotic medication. Al-
though data are not presented by Kebede et al.,
42 one
might reasonably conjecture that the baseline high rate
of continuous course of illness (67.2%) among subjects
was, at least in part, the result of lack of treatment. At
1- to 4-year follow-ups, subjects displayed a significant
improvement in positive symptoms, a result attributed
to the antipsychotic medication that was offered free
of charge to all subjects.
33
A community survey in Chennai,India, identifiedaco-
hort of 261 persons with a diagnosis of schizophrenia, of
whom 28.7% had never received treatment even though
they lived within 10 km of 4 public general hospitals with
psychiatric units and 1 large mental hospital.
36 Com-
pared with those who had received treatment, those in
the untreated group were, on average, older and more
likely to be unemployed, illiterate, and living in an ex-
tended family. Clinically, the untreated group was
more likely to be symptomatic and suffering from severe
global disability. Free treatment was offered to those in
the untreated group and 49 accepted.
45 At 1-year follow-
up, 69.4% of these subjects continued in poor clinical sta-
tus, an outcome that was found to be associated with
DUP.
46 DUP was also found to be a predictor of out-
come in South Africa.
47,48
In rural Karnataka, Murthy et al.
41 identified 100 per-
sons with schizophrenia who had not received antipsy-
chotic treatment in the previous 6 months. Scores on
severity of symptoms, levels of disability, and extent of
Table 4. Clinical Outcomes or Patterns of Course, Retrospective Studies
Site
Psychiatric
Assessment
Follow-up
(y)
d Clinical Outcomes
s Patterns of Course (%)
Bali, Indonesia
24,89 PANSS 5 d 77.00: Total score (moderately ill
91)
Ibadan, Nigeria
63 PSE 7–26 d 50.7: No psychotic symptoms
d 23.9: Persistent neurotic symptoms or drug reactions
a
d 25.4: Chronic psychosis or  3 relapses
SANS
Note: PANSS, Positive and Negative Symptom Scale; PSE, Present State Examination; SANS, Scale for Assessment of Negative
Symptoms.
aAlso includes reports of negative social behavior from relatives or employer.
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Site
Functional
Assessment
Follow-up
(y) Follow-up Status (%)
Chennai, India
43 WHO/DAS 1 d 73.4: Moderate to severe global disability
a
d 34.7: No impairment in social functioning
d 51.0: No impairment in occupational functioning
Rural Karnataka, India
41 WHO/DAS II 1.5 Overall disability
d Significant reduction (P = <.001) from baseline
Sa ˜o Paulo, Brazil
64 WHO/DAS 2 Social functioning
d 54.3: Social withdrawal
b
d 37.2: Self-care
c
d 52.2: Interest and information
d
Sichuan, China
29 SDSS 2 Social functioning
d 20.9: Mildly impaired
d 10.9: Moderately impaired
d 68.2: Seriously impaired
Multisite study, India
22,25,26 PPHS 2 Social interaction
d 33.7: No impairment
d 53.6: Some impairment
d 12.7: Severe impairment
PSE
Ilesa, Nigeria
53 NA 2.1–3.2 Social relationships
d 43.6: Satisfactory
d 23.4: Moderate problems
d 22.3: Severe problems
d 10.6: NA
Butajira, Ethiopia
33,42 SF-36 1–4 d Functional status generally poorer in Butajira than in
industrialized countries
e
Multisite study, India
22,25,26 PPHS 5 Social interaction
d 25.8: No impairment
d 52.6: Some impairment
d 21.6: Severe impairment
PSE
Bali, Indonesia
23 ESAS 11
f
d 39.1: Self-supportive
d 13.0: Semi self-supportive
d 15.2: Socially adjusted to family or community
d 32.6: Maladjusted
Madras Longitudinal Study, India
20 GAF 20 GAF functioning
d 73.8: None or some difficulty in social and occupational
domains
WHO studies
Sofia, Bulgaria
15 GAF-D 16 GAF-D
d 32.7: No or minimal social disability
d 36.4: Poor functioning
DAS DAS
d 32.7: No or minimal disability
d 36.4: Poor social functioning
China (ISoS)
15 GAF-D 12 d 32.8: Good social functioning
d 39.6: Serious impairment in social functioning
g
Cali, Colombia (ISoS)
15 GAF-D 26 GAF-D
d 45.8: No or minimal social disability
d 27.8: Mild social disability
d 23.6: Moderate social disability
d 2.8: Severe social disability
DAS DAS
d 52.3: Good to excellent social functioning
d 9.0: Poor social functioning
d 0.0: Severe social functioning
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Questioning an Axiomfamily burden were all high at baseline. Following 18
months of treatment with antipsychotic medication
and psychosocial care, the cohort displayed, on average,
significant improvements in all domains.
In sum, these findings suggest that good outcomes can-
not be assumed for untreated schizophrenia in low- and
middle-income countries and that treatment does make
a significant difference.
Mortality and Suicide
Throughout the world, persons with schizophrenia have
rates of mortality that are significantly higher than gen-
eral populations.
49 That this is the case in low- and mid-
dle-income countries is suggested by the crude mortality
data in table 2. In long-term studies ( 10 years), mortal-
ity rates range from 9.0% to 30.7% in the ISoS sites (ur-
ban Chandigarh and Agra, respectively) and from 10.0%
to19.2%and20.3%inotherresearchsites (Chennai,Bali,
Indonesia, and rural China, respectively). It is likely that
the reported mortality rates are underestimates given the
lack of information about subjects lost to follow-up.
Crudemortalityratesdonotindicatehowpersonswith
schizophrenia compare to general populations. Stan-
dardized mortality ratios (SMRs) provide that measure.
Wherever SMRs are available, there is little question that
persons with schizophrenia in low- and middle-income
countries have elevated rates of mortality.
49,50 The re-
search by Ran et al.
51 is particularly revealing because
of its large sample size (510), low rate of attrition
(7.8%), and long-term follow-up (10 years). The SMR
for the cohort was 4.0; the rate among men (4.9) was
higher than it was among women (3.3). Suicide and death
byaccidentaccountedformuchoftheelevatedSMR,but
not all of it: the SMR for natural causes was 2.6. SMRs
for men in the Sa ˜o Paulo, Brazil cohort,
52 were (4.5), but
those for women were nearly seven times as high (25.5).
Other studies offer information about the context in
which high rates of mortality occur. Of 9 known deaths
in a Nigerian cohort, 5 took place while subjects were ‘‘in
traditionalhealers’establishments’’while2othersubjects
‘‘had been beaten to death by night guards who had
found them wandering.’’
53 In Indonesia, of the 11 sub-
jects who died of natural causes, only 2 were receiving
medical treatment at the time of their deaths.
54 The av-
erage age of death in this cohort, 33.3 years, was strik-
ingly similar to that in the MLS, 34.2 years.
20 In
contrast, life expectancies for general populations in
Indonesia and India are approximately 65 and 61 years,
respectively.
Table 5. Continued
Site
Functional
Assessment
Follow-up
(y) Follow-up Status (%)
Agra, India (ISoS)
15 GAF-D 25 GAF-D
d 48.7: Better functioning—men
d 81.8: Better functioning—women
DAS DAS
d 60.0: Good to excellent adjustment
d 19.0: Fairly good functioning
d 21.0: NA
Chandigarh (rural), India (ISoS)
15 GAF-D 15 d 71: Good to excellent social functioning
d 5: Serious impairment in social functioning
Chandigarh (urban), India (ISoS)
15 GAF-D 15 d 63: Good to excellent social functioning
d 14: Serious impairment in social functioning
Ibadan, Nigeria
11 NA 2 % of follow-up social functioning unimpaired
d 65.6: 76–100
d 15.6: 46–75
d 7.3: 16–45
d 11.5: 0–15
Note: GAF-D, Global Assessment of Functioning-Disability; WHO/DAS, World Health Organization Disability Assessment Scale;
SDSS, Social Disability Screening Schedule; PPHS, Psychiatric and Personal History Schedule; PSE, Present State Examination; SF-36,
Medical Outcomes Study Short Form; PPHS, Psychiatric and Personal History Schedule; PSE, Present State Examination; ESAS,
Eguma’s Social Adjustment Scale; GAF, Global Assessment of Functioning; ISoS, International Study of Schizophrenia.
aAt baseline, 98.7% of subjects assessed as having severe global disability.
bAt baseline, 74.3%.
cAt baseline, 55.7%.
dAt baseline, 68.2%.
eComparisons of mean differences in social and physical functioning and role limitations between subjects and general population. At
baseline, 7% were homeless.
fFive-year retrospective study served as baseline.
gTendency for men to have higher levels of social functioning than women (GAF-D, 62.9 vs 58.3 for men and women, respectively).
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A. Cohen et al.Table 9 summarizes the information that is available
about suicide. The studies in rural China,
51 Brazil,
52
the MLS,
20,21 and Bulgaria
15 suggest that rates of suicide
are comparable to, if not higher than, the lifetime rates
(4.9%–5.6%) reported by Palmer et al.
55 In contrast,
there were no reported suicides in the 1-year studies in
Chennai,
46 Rural Karnataka,
41 and the 11-year study
in Indonesia.
23,24,54 In general, data on suicide must be
viewed with caution. For example, the reported rate of
suicide in the MLS (7.8%) may have been an under-
estimate: ‘‘Because postmortem examinations were not
done, it was not possible to determine the actual cause
of death in some cases.’’
20
The Role of Families
There is a long history to the notion that the better course
andoutcomeofschizophreniainlow-andmiddle-income
countries is attributable to relatively high levels of family
support and tolerance.
9,15 This view has been maintained
despite a paucity of evidence.
56,57 The research literature
reviewed here provides evidence that, at the very least,
should make us question past assumptions. For example,
the Indian family has been noted as being especially sup-
portive of members with schizophrenia.
58,59 We do not
doubt this view, but do believe it may be an overgener-
alization. While it is true that over the course of 20 years,
the great majority of subjects in the MLS lived with their
natal or marital families,
20,21 research also offers insights
about the nature of subjects’ family relationships. At the
same time that families supported mentally ill members
anddidnotabandonorpushthemintohomelessness,un-
employed men with schizophrenia were subjected to ‘‘re-
jection and harsh criticism.’’
44 Other evidence from
Chennai suggests that living in an extended family is
a risk factor for not being brought to care, even when liv-
ingincloseproximitytofacilitiesthatoffertreatmentfree
of charge.
43 Finally, ethnographic research in Chennai
with a group of separated and divorced women with
schizophrenia (but not part of any outcome study) found
that their lives were marked by ‘‘hostility from family
members.’’
60
Evidence from other countries adds still more com-
plexity. Whereas less than 2% of ISoS subjects experi-
enced homelessness in the 2 years prior to follow-up
(an admitted underestimate),
15 higher rates of homeless-
ness were found among samples in rural areas of China
61
and Ethiopia
42 (8% and 7%, respectively). In a 13-year
retrospective study, Gureje and Bamidele
35 were sur-
prised, ‘‘given the traditional family structure in Nigeria,’’
that 4% of subjects were homeless or experiencing hous-
ing instability. They speculated, ‘‘In a setting where there
are no public support services for the mentally ill, it is
likely that the traditionally supportive family networks
break down with prolonged illness.’’ Evidence from rural
China also belies the notion of universal family tolerance
and support of members with schizophrenia in that ‘‘in-
sufficient family care or maltreatment’’ was associated
with poor clinical status.
48
In sum, the research literature suggests that we must
not make broad assumptions about the nature of family
support for persons with schizophrenia. Support cer-
tainly exists, but it may be mixed with conflict or even
breakdown in the absence of supports for the families
themselves.
Gender
It is generally accepted that women with schizophrenia
experience better outcomes than men.
62 Although, gender
Table 6. Disability Outcomes, Retrospective Studies
Site
Functional
Assessment Follow-up (y)
Follow-up
Status (%)
Bali, Indonesia
23,24,89 ESAS 5
a
d 34.8: Self-supportive
d 19.6: Semi self-supportive
d 30.4: Socially adjusted to family or community
d 15.2: Maladjusted
Ibadan, Nigeria
63 NA 7–26 d Women deteriorated rapidly in social domains (employment,
marriage, and education) after ﬁrst episode
d Men tended to be ‘‘better adjusted at home’’
Abeokuta, Nigeria
35 GSDS 13 Social Outcome
b
d 22: Unimpaired
d 19: Some impairment
d 23: Moderate impairment
d 36: Severe impairment
Note: ESAS, Eguma’s Social Adjustment Scale; GSDS, Gronigen Social Disability Scale.
aBased on scores of 46 subjects remaining in sample at 11-y follow-up.
bMore women than men had impaired social outcomes (P = .03).
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Questioning an AxiomTable 7. Marital Status
Site
Marital Status
d Baseline
s Follow-up (%) National Rates
92
Sa ˜o Paulo, Brazil
37,38
d 16.9: Married
d 65.3: Single
d 15.4: Separated/divorced
d 2.4: Widowed
1980, urban, 15þ y
56.2: Married
35.5: Single
2.9: Separated/divorced
5.3: Widowed
Sichuan, China
29 d 41.7: With partner
d 58.3: No partner
1995, rural, 15þ y
72.8: Married
20.1: Single
0.6: Separated/divorced
6.5: Widowed
Butajira, Ethiopia
32,33
d 30.0: Married
a
d 52.1: Never married
d 17.9: Separated/divorced/widowed
2000, total, 15þ y
57.3: Married
b
34.3: Single
6.3: Divorced
2.0: Widowed
India
Madras Longitudinal Study
20,31 10 y
s 69.7: Ever married
c
s 31.3: Never married
1999, total, 15þ y
69.5: Married
22.0: Single
1.0: Separated/divorced
7.5: Widowed
20 y
s 73.7: Married
s 26.3: Single
Chennai
36,43
d 60.9: Ever married
d
d 39.6: Ever divorced/separated
s 67.3: Poor marital statuse
Rural Karnataka
41
d ’50
f
Bali, Indonesia
23,24 5y
s 51.0: Married
s 49.0: Single
1997, total, 15–49 y
69.7: Married
25.3: Single
2.5: Separated/divorced
2.5: Widowed
11 y
s 63.0: Ever married
g
Nigeria
Ilesa
53
s 16.0: Married, satisfactory
s 7.4: Married, problems
s 16.0: Complete breakdown of marriage
s 51.1: NA
s 9.6: Dead
1991, total, 15–79 y
62.4: Married
30.5: Single
2.6: Separated/divorced
4.5: Widowed
Abeokuta
35
d 28.3: Married
h
d 27.5: Separated/divorced
d 39.2: Never married
d 5.0: Widowed
Ibadan
11
d 44.4%: Single
d 48.5%: Married/cohabitating
d 5.8%: Divorced/separated/widowed
d 1.2%: Other/not known
aAt follow-up, 28.8% of sample were married.
bIncludes consensual union.
cBy 10-y follow-up, 9 marriages (6 women, 3 men) had ended in divorce.
dOf 261 subjects at baseline (4 subjects no information).
eOf those, 49 subjects untreated at baseline and followed-up.
f‘‘A little over half.were currently married.’’
gOne divorced and 1 widowed.
hMen (66.1%: never married, 14.3%: married, 17.9%: separated/divorced, 1.8%: widowed); Women (15.6%: never married, 40.6%:
married, 35.9%: separated/divorced, 7.8%: widowed).
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Site
Employment Status
d Baseline (No Information at
Follow-up)
s Follow-up (%)
Sa ˜o Paulo, Brazil
38 d 19.3: Working regularly
d 7.3: Some activity
d 10.5: Housewife
d 10.5: Retired
d 11.3: Sickness benefit
d 41.1: No occupation
Sichuan, China
29
d 32.1: Full-time farm work
d 45.5: Part-time farm or
household work
d 22.4: No work
Butajira, Ethiopia
42
d 50.3: Full-time work
d 4.4: Domestic work
d 45.3: Unemployed
India
Chandigarh
28
s 39.6: Working/no impairment
s 16.5: Working/some
impairment
s 44.0: Not working
Multisite study
22,25,26 2y
s 40.2: Working/no impairment
s 42.2: Working/some
impairment
s 17.6: Not working
Multisite study
22,25,26 5y
s 39.0: Working/no impairment
s 43.2: Working/some
impairment
a
s 17.8: Not working
MLS
44,45 10 y Men
s 52.5: Good occupational
outcome
b
s 47.5: Poor occupational
outcome
c
Women
s 66.7: Good home-making
function
d
s 33.3: Poor home-making
function
e
MLS
20 20 y Men
s 76: Employed
f
Women
s 75: Housewives or unmarried
living with parents
s 25: Employed
g
Chennai
43
s 51.0: No impairment in job/
housework function
h
Rural Karnataka
41
d 13: Regular employment
Bali, Indonesia
23 11 y
s 37.0: Employed full time
s 21.7: Employed part time
s 41.3: Unemployed
Jamaica
39
s 43: ‘‘Gainful employment’’
during follow-up
Nigeria
Ilesa
53
s 36.2: Working
s 52.3: Not working
s 9.6: Sead
Lagos
90
s 56.6: Maintained employment
Table 8. Continued
Site
Employment Status
d Baseline (No Information at
Follow-up)
s Follow-up (%)
Abeokuta
35 s 51.7: Little or no disruption in
occupation
s 25: Significant work
disruptions
i
s 13: Totally incapacitated
Trinidad
88
d 23.9: Employed
d 34.8: unemployed
d 41.3: No information
WHO studies
Sofia, Bulgaria
15 Past 2 y
d 45.3: Some paid employment
d 13.1: Full-time household work
China
15 Past 2 y
d 27.6: Some paid employment
j
d 34.5: Household work
d 41.4: Retired
k
Cali, Colombia
15
d 68: Employed
l
d 18: Full-time household work
d 14: NA
Agra, India
15
d 44.3: Employed
m
d 34.4: Household activities
d 4.9: Retired
d 9.8: Unemployed
d 6.6: NA
Chandigarh (rural), India
15 Past 2 y
d 45: Some paid employment
n
d 58: Full-time household work
Chandigarh (urban), India
15Past 2 y
d 64: Some paid employment
o
d 28: Fulltime household work
Note: MLS, Madras Longitudinal Study,
aIn general, men’s employment was ‘‘erratic and irregular
consequent to the illness.’’
bNo change or improvement in employment or income status
during follow-up.
cDeterioration in employment or income status during
follow-up.
dPerformed regular housework  50% of follow-up.
ePerformed regular housework  50% of follow-up.
fHalf full-time, others part-time or in family business. Of those
employed, two-thirds had minimal or no impairment in work.
gMostly intermittent employment.
hSeven subjects (14.3% of sample) unemployed at inclusion gained
employment during follow-up.
iIn all, 4.6% of men and 51.5% of women were rated as having
poor occupational outcomes.
jAbout two-thirds of these subjects had worked for 12 mo or
more.
kA small proportion of this category included in other
categories.
lOf these, 59% were employed full-time during previous 2 y.
mIn rural areas of Agra, employment was ‘‘in routine, rustic
jobs—such as taking cattle to graze and feed—tasks which
family members judged them to be performing well.’’
nOf these, 37% were employed for the entire 2 y.
oOf these, 54% were employed for the entire 2 y.
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Questioning an Axiomeffects were not explored consistently in the research we
reviewed, some observations are possible. In India, sev-
eral studies found that course and outcome is better for
women.
15,21,26,30 However, that was not the case
everywhere. Men tended to have better outcomes in
Colombia.
15 In the ISoS China study,
15 there were few
gender differences, but women tended to do better in
the study by Ran et al.
29 in rural China. In Nigeria,
women seemed more likely to suffer from continuous
psychosis and were particularly prone to relapse.
63
Outcomes in social domains also displayed gender
effects. In Nigeria, women tended to fare worse than
men,whilewomeninEthiopiatendedtoshowgreaterim-
provement in functioning during follow-up.
33 In ISoS,
men in China also tended to have higher levels of social
functioning. This was in contrast to Agra where 81.8% of
women were rated as having ‘‘better functioning at fol-
low-up,’’ a rate more than 1.5 times that of men.
15
The most striking gender effect was in Ethiopia where
a community survey found a 5:1 male to female ratio in
the prevalence of schizophrenia.
33 Whether this reflects
an exceptional case of gender differences in frequency,
excess mortality, or that women with schizophrenia
are being kept extremely isolated requires further
investigation.
Conclusions
During the past 30 years, international psychiatry has
embraced the notion that the course and outcome of
schizophrenia is better in so-called ‘‘developing’’ coun-
tries.
2–5,13,14 We believe our review of 23 studies in 11
low-andmiddle-incomecountries—amuchgreaterrange
of sociocultural environments than in ISoS—provides
enough evidence to justify a reexamination of this axiom.
First,thereappearstobegreatvariationinclinicalout-
comes and patterns of course. Whereas, some studies in
India strongly support the ‘‘better prognosis’’ hypothe-
sis,
15,20,21outcomes do notappeartobe nearlyas positive
in Brazil
64 and China.
29 Additionally, limited evidence
suggests that gender effects vary cross-nationally.
Second, similar patterns are found in the domains of
disability and social functioning: good in most studies in
India
15,20,21 and Indonesia,
23 but poorer in Nigeria,
35,53
and much poorer in a cohort of untreated persons in
Chennai, India.
43 Social functioning by gender also
varied: in the MLS, women had high levels,
26,45 while
in Nigeria women fared poorly.
35,63 Outcomes in occupa-
tional and marital status also varied. A more important
point, however, is that status in these 2 domains must be
interpreted in the context of sociocultural norms and
assessed, at least to some degree, qualitatively. Viewed
fromthisperspective,thedataintable7suggestthatrates
of marriage for people with schizophrenia are relatively
low and rates of divorce/separation are high.
With regard to occupational status, ‘‘the crude distinc-
tionbetween‘employment’and‘unemployment’’’
39isun-
informative because the role of work in shaping the
course and outcome of schizophrenia has not been ex-
plored adequately.
56 For example, what are the effects
on outcome of farm work in rural Ethiopia
42 or China?
29
Did jobs ‘‘in the unorganized/informal sector [as] street
vend[ors], shops assistants, and domestic help’’ impel
good outcomes in the MLS?
44
Furthermore, assessment of social functioning is, in
general, ‘‘fraught with problems’’
27 given variation in so-
ciocultural environments, norms, and attitudes.
3 Unfor-
tunately, neither the research reviewed above nor the
WHO studies provide the evidence that allows us to eval-
uate the quality of family and social interactions, the na-
ture of employment, and the meaning of marriage for the
subjectsinthe variousstudies.Ethnographicmethodsare
needed to gain a better understanding of the social func-
tioning of persons with schizophrenia in a range of socio-
cultural environments.
18,19
Third, the WHO studies have led ‘‘to the ironic obser-
vation that abundance cripples’’ and that ‘‘scarcity’’ and
‘‘collaborative social world[s]’’ are responsible for better
outcomes.
56Yet,ourreviewoftheresearchsuggestsadif-
ferent conclusion: wherever it is found, lack of care is as-
sociated with relatively poor outcomes and that accessing
care is associated with improved outcomes. Because the
individuals in many of the studies were receiving care at
leading academic psychiatric facilities, one might even
say that their relatively good clinical, occupational,
and social outcomes reflected the effects of quality
care as much as, if not more than, the effects of sociocul-
tural environments. Thus, the favorable outcomes that
have been found by some studies cannot be assumed
Table 9. Suicide
Site Years Suicide %
Sa ˜o Paulo, Brazil
52 2 4.3
Sichuan, China
51 10 4.2
Butajira, Ethiopia
33 1–4 NA
India
Multisite study
22,25 2 2.1
5 3.1
Madras Longitudinal
Study
20,21
10 5.6
20 7.8
Chennai
46 1 0.0
Rural Karnataka
41 1.5 0.0
Bali, Indonesia
23,24,54 11 0.0
ISoS
15
Sofia, Bulgaria 16 3.6
Beijing, China 12 2.2
Cali, Colombia 26 1.0
Agra, India 25 2.9
Chandigarh, urban, India 15 2.6
Jamaica
39 1 0.0
Ilesa, Nigeria
53 2.1–3.2 0.9
Note: ISoS, International Study of Schizophrenia.
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A. Cohen et al.to be representative of outcomes in low- and middle-
income countries where the majority of persons with
schizophrenia have little or no access to care.
Fourth, the evidence about excess mortality must not
be ignored. We agree with Ran et al.
51: ‘‘It may be pre-
mature to suggest that there is a better prognosis for
schizophrenia in [developing] countries if withdrawals
or attrition due to death.are not included in follow-
up analyses.’’
Fifth, further research into the role of families is nec-
essary. Although expressed emotion studies are informa-
tiveaboutthenature offamilyinteractions,suchresearch
provides little understanding of the processes that for
example, lead Indian families to keep members with
schizophrenia out of care, or that bring about the break-
down of family support for subjects in Nigeria, or that
force homelessness upon some persons with schizophre-
nia in China. Surveys of public attitudes in Nigeria
65,66
and Ethiopia,
67 as well as qualitative and survey research
with families in India
60,68–70 suggest high levels of stigma
about mental illness. These negative attitudes, at least in
Africa, are believed to result in families abandoning men-
tally ill members.
71 Appalling conditions in psychiatric
facilities in Asia
72–74 also raise questions about whether
presumed tolerance translates into better outcomes.
Sixth, variability in outcomes is evident in high-income
countries, too. Reviews of long-term studies
16,75,76 show
variability from study to study, and ISoS
15 shows vari-
ability in outcomes across high-income countries. One
analysis of DOSMeD data
77 indicates that 2-year out-
comes in Prague and Nottingham were similar to those
in India, while outcomes in Cali were close to those in
high-income countries. Given this variation, we need
to find a better framework for comparing schizophrenia
outcomes in different sociocultural environments.
Seventh, the evidence provided by this review suggests
that the sampling methods utilized in the WHO studies
may have resulted in overly optimistic perceptions of
course and outcome in low- and middle-income coun-
tries. Except for the China ISoS site, sampling in all
the WHO studies relied on a variety of help-seeking
agencies to identify potential subjects.
10,11,15 However,
community surveys in rural China,
29 India,
36,43,46
Indonesia,
78 and Ethiopia have shown that large propor-
tions of persons with schizophrenia (between about 25%
and almost 90%) never receive biomedical treatments.
Furthermore, outcomes in these samples, whether or
not subjects received treatment following inclusion in
the studies, tended to be poor. Therefore, there is the
possibility that case-finding methods which focus exclu-
sively on help-seeking agencies will miss large propor-
tions of seriously ill, poor prognosis individuals.
This review has 2 main limitations. First, our strategy
to identify studies—searches of bibliographic databases
and locating references cited in journal articles—may
not have been comprehensive, and it is possible that
we did not find all the studies that met our criteria. It
is also possible that reliance on English language articles
excluded a number of reports about other outcome stud-
ies. Nevertheless, because this was a narrative review and
not a meta-analysis, we do not believe these potential
shortcomings would have substantially influenced our
conclusions. Second, a more serious limitation is the pos-
sibility that apparent variations in course and outcome
were the function of methodological heterogeneity
among the studies. We do not believe this was the case
because the methods and instruments used in the studies
were generally consistent with each other.
In conclusion, we suggest it is time to revisit the hy-
pothesis that the course and outcome of schizophrenia
is better in low- and middle-income countries. Although
a host of sociocultural factors have been cited as contrib-
uting to variation in the course and outcome of schizo-
phrenia—eg, family support and styles of interaction,
industrialization, and urbanization
4—there is little direct
evidence, and what exists provides little help in unpack-
ing the ‘‘black box’’ of culture.
79 Clinical, epidemiologi-
cal, and ethnographic research are required to better
understand how neuropsychiatric processes and social
worlds interact to shape the lives of persons with schizo-
phrenia in low- and middle-income countries.
The questions in need of investigation include:
  Of the prevalent cases in each catchment area, how
many are receiving psychiatric care? How many are re-
ceiving alternative forms of treatment? How many are
receiving no care at all?
  What are the biomedical and other treatment effectson
outcome? How do variations in treatment influence
variationsinoutcomeswithinandacrossresearchsites?
  What are the clinical outcomes in terms of positive and
negative symptomatology of incident and prevalent
cases?
  How might employment and nonpaid occupations in-
fluence or be influenced by clinical factors?
  What is the quality of family life (natal and marital) of
personswithschizophreniaandhowdoesthisinfluence
(or is influenced by) outcome?
  What are the pathways to care (biomedical and tradi-
tional) and what are the clinical and sociocultural fac-
tors associated with help-seeking decisions?
  What are the circumstances that lead to suicidality and
excess mortality among persons with schizophrenia?
The knowledge that will come from answering these
and other questions is important for at least 3 reasons.
First, identifying the processes that promote good prog-
nosis will inform the care and treatment of persons with
schizophrenia wherever they live. Second, accurate infor-
mation about the realities of the day-to-day lives of per-
sons with schizophrenia in low- and middle-income
countries will inform advocacy efforts to: (a) close the
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Questioning an Axiomenormous gap between the numbers of people in need of
care and the small number who actually receive it
80; and
(b) provide greater supports for families. Finally, global-
ization is bringing about enormous sociocultural and
socioeconomic changes to the societies of low- and middle-
income countries. In turn, these changes will, inevitably,
transform the nature of families and the communities in
which they live, the epidemiological profile of nations
and regions, and the services provided by health systems.
No doubt, globalization will have significant consequen-
cesforthelivesofpersonswithschizophrenia.Toprevent
or at least limit the potential harm that may result, it is
essential that wehave detailedunderstandingsabouthow
sociocultural and psychiatric processes interact. For
these reasons, it would make sense to put aside presumed
wisdom and reexamine the question of the prognosis of
schizophrenia in low- and middle-income countries.
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